Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple blood test predict severe preeclampsia?

NCT ID NCT07265336

Completed Knowledge-focused Sponsor: Saint Thomas Hospital, Panama Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study looks at whether a blood gas measurement called base excess differs between pregnant women with severe preeclampsia and those with normal blood pressure. Researchers will test 100 women before delivery to see if abnormal base excess levels are linked to more severe disease. If confirmed, base excess could become a new tool to help predict complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help identify a simple blood test marker to predict the severity of preeclampsia, potentially guiding earlier interventions.
What could go wrong
This is an early observational study with only 100 participants, so results may not apply to all patients. The link between base excess and preeclampsia severity is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia severe pre-eclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREECLAMPSIA SEVERE PREECLAMPSIA

Contacts and locations

Locations

  • Saint Thomas Hospital

    Panama City, Provincia de Panamá, Panama

More trials for these conditions

Other studies related to the condition(s) this trial covers.